AN OPEN LABEL STUDY OF THE SAFETY AND TOLERABILITY OF ST101 IN SUBJECTS WITH ALZHEIMER
M
Martin Farlow, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
No Description Available
Description
No Description Available
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Alzheimer
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
24 Apr 2024.
Study ID: 0909-02